These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 8628368)

  • 1. Intensity of hemodialysis and response to erythropoietin.
    Uréna P; Pétrover M
    N Engl J Med; 1996 Jun; 334(25):1669; author reply 1670-1. PubMed ID: 8628368
    [No Abstract]   [Full Text] [Related]  

  • 2. Intensity of hemodialysis and response to erythropoietin.
    Kotanko P
    N Engl J Med; 1996 Jun; 334(25):1670; author reply 1670-1. PubMed ID: 8628371
    [No Abstract]   [Full Text] [Related]  

  • 3. Intensity of hemodialysis and response to erythropoietin.
    Malhotra D; Tzamaloukas AH
    N Engl J Med; 1996 Jun; 334(25):1669-70; author reply 1670-1. PubMed ID: 8628369
    [No Abstract]   [Full Text] [Related]  

  • 4. [Beneficial effect of AN69 membranes on anemia in hemodialyzed patients].
    García Cortés MJ; Sánchez Perales MC; Liébana A; Gil JM; Borrego FJ; Borrego J; Pérez del Barrio P; Serrano P; Pérez Bañasco V
    Nefrologia; 2001; 21(4):370-5. PubMed ID: 11816513
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Use of erythropoietin in patients with chronic renal insufficiency and in hemodialysis].
    Cuero CJ; Pérez Guardia E; de Rivera C
    Rev Med Panama; 1996; 21(1-2):55-9. PubMed ID: 8966240
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of erythropoietin in predialysis patients.
    Anderson S
    Am J Kidney Dis; 1991 May; 17(5 Suppl 1):103-6. PubMed ID: 2024665
    [No Abstract]   [Full Text] [Related]  

  • 7. [A hematocrit greater than 36 lessens mortality and hospitalization in hemodialysis].
    Fernández-Gallego J; Gutiérrez C
    Nefrologia; 2003; 23(2):177-8. PubMed ID: 12778885
    [No Abstract]   [Full Text] [Related]  

  • 8. [Low doses of recombinant erythropoietin in the treatment of renal anemia in patients on chronic hemodialysis and ambulatory peritoneal dialysis].
    Lashutin SV; Nikolaev AIu; Ermolenko VM; Shutov EV; Bezruk VG; Ivashchenko MA
    Ter Arkh; 1999; 71(6):61-3. PubMed ID: 10420460
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intensity of hemodialysis and response to erythropoietin.
    Ballinger AB; Fairclough PD; Clark ML; Farthing MJ
    N Engl J Med; 1996 Jun; 334(25):1670; author reply 1670-1. PubMed ID: 8628370
    [No Abstract]   [Full Text] [Related]  

  • 10. [Etiopathogenic mechanisms of anemia in hemodialysis patients].
    Marco Franco JE; Alarcón Zurita A; Dalmau Diana M; Pizá Buñola C; Morey Molina A; Bestard Palmer J; Mairata Bosch S; Ribas Mundó M
    Rev Clin Esp; 1983 Jan; 168(2):83-5. PubMed ID: 6344155
    [No Abstract]   [Full Text] [Related]  

  • 11. Anemia and erythropoietin in hemodialysis and continuous ambulatory peritoneal dialysis.
    Korbet SM
    Kidney Int Suppl; 1993 Feb; 40():S111-9. PubMed ID: 8445832
    [No Abstract]   [Full Text] [Related]  

  • 12. Dialysis dose, membrane type, and anemia control.
    Young EW
    Am J Kidney Dis; 1998 Dec; 32(6 Suppl 4):S157-60. PubMed ID: 9892384
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Normalization of hematocrit in regular hemodialysis patients: the role of renal cyst formation.
    Ono K; Kikawa K; Okamoto T; Matsuo H
    Trans Am Soc Artif Intern Organs; 1985; 31():639-43. PubMed ID: 3837523
    [No Abstract]   [Full Text] [Related]  

  • 14. [Countermeasure for patients with anemia due to hemodialysis].
    Suzuki M
    Nihon Naika Gakkai Zasshi; 1995 Oct; 84(10):1663-7. PubMed ID: 8537721
    [No Abstract]   [Full Text] [Related]  

  • 15. [Evolution of medical practice in the care of anemia amd the use of erythropoietin in chronic renal insufficiency hemodialysis in the past six years].
    Canaud B; Richard A; Fagnani F; Moreau-Defarges T; Guillon P
    Nephrologie; 2002; 23(3):123-30. PubMed ID: 12087809
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The effect of calcitriol on renal anemia in patients under chronic hemodialysis].
    Abou-Khalil N; Makó J
    Orv Hetil; 1996 Jul; 137(27):1469-72. PubMed ID: 9173368
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Erythropoietin treatment for anemia in end-stage renal disease with diabetes mellitus.
    Nakatsuka K; Hino M; Miki T; Nishizawa Y; Tabata T; Inoue T; Morii H
    Diabetes Care; 1990 Nov; 13(11):1130-1. PubMed ID: 2261828
    [No Abstract]   [Full Text] [Related]  

  • 18. Anemia in patients on maintenance hemodialysis: the effect of parathyroid hormone.
    Kostić S; Strahinjić S; Dordević V; Stefanović V
    Acta Med Iugosl; 1986; 40(2):133-7. PubMed ID: 3728075
    [No Abstract]   [Full Text] [Related]  

  • 19. The use of IV iron in the treatment of anaemia of ESRD patients on maintenance haemodialysis: an historical and personal view.
    Shaldon S
    Nephrol Dial Transplant; 2007 Jan; 22(1):23-5. PubMed ID: 17088269
    [No Abstract]   [Full Text] [Related]  

  • 20. Reticulocyte count used to assess recombinant human erythropoietin sensitivity in hemodialysis patients.
    Tatsumi N; Kojima K; Tsuda I; Yamagami S; Itoh Y; Tanaka H
    Contrib Nephrol; 1990; 82():41-8. PubMed ID: 2093525
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.